Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AravivePhaseBio PharmaceuticalsNewron PharmaceuticalsIDEAYA BiosciencesMonopar Therapeutics
SymbolNASDAQ:ARAVNASDAQ:PHASOTCMKTS:NWPHFNASDAQ:IDYANASDAQ:MNPR
Price Information
Current Price$5.37$2.85$7.50$3.59$6.40
52 Week RangeBuyBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$26.00$20.67N/A$18.00$42.00
% Upside from Price Target384.17% upside625.15% upsideN/A401.39% upside556.25% upside
Trade Information
Market Cap$77.78 million$87.49 million$133.83 million$77.51 million$74.59 million
Beta2.42.080.04N/AN/A
Average Volume156,117303,6131065,9436,590
Sales & Book Value
Annual Revenue$4.75 million$2.36 million$7.88 millionN/AN/A
Price / Sales16.9834.7616.98N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.36 per share$2.08 per share$3.63 per share$4.94 per shareN/A
Price / Book1.001.372.07N/AN/A
Profitability
Net Income$-18,220,000.00$-23,850,000.00$-22,640,000.00$-41,970,000.00$-4,220,000.00
EPS($1.57)($1.43)($1.27)($3.36)($0.45)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A15.63N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-1,662.30%N/AN/AN/A
Return on Equity (ROE)-32.47%-59.92%N/AN/A-60.03%
Return on Assets (ROA)-25.70%-49.05%N/AN/A-55.57%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.11%0.13%N/A0.06%N/A
Current Ratio13.73%13.98%N/A14.65%18.27%
Quick Ratio7.59%13.98%N/A14.65%10.56%
Ownership Information
Institutional Ownership Percentage42.87%67.69%N/A51.16%0.25%
Insider Ownership Percentage39.80%17.00%N/AN/AN/A
Miscellaneous
Employees142224564
Shares Outstanding15.02 million28.78 million17.84 million20.34 million10.62 million
Next Earnings Date5/13/2020 (Estimated)5/14/2020 (Estimated)6/4/2020 (Estimated)6/23/2020 (Estimated)6/26/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel